BiomX Inc. Insider Trading
PHGE
Insiders sold $8.25M and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Reuven Yeganeh sold $4.9M on Mar 17, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2023.
Get an email when PHGE's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 16 – 17 | Reuven Yeganeh Director | SoldNo plan 2 parts | 980,000 | $5.00 average | $4.9M | 100% | Form 4 |
| Mar 12 – 13 | Reuven Yeganeh Director | SoldNo plan 2 parts | 670,000 | $5.00 average | $3.35M | 100% | Form 4 |
- Mar 16 – 17No planReuven YeganehDirector · sold 980,000 at avg $5.00$4.9M100% of stake
- Mar 12 – 13No planReuven YeganehDirector · sold 670,000 at avg $5.00$3.35M100% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Services-Prepackaged Software · Pick stocks to compare with PHGE
Spot a number that looks wrong? Check it in PHGE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PHGE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.